The expression of co-stimulatory molecules and their relationship to the prognosis of human acute myeloid leukaemia: Poor prognosis of B7-2-positive leukaemia

British Journal of Haematology

Volumn 102, Issue 5, 1998, Pages 1257-1262

  Maeda, Akinori ^a   Yamamoto, Kokichi ^a   Yamashita, Kouhei ^a   Asagoe, Kohsuke ^a   Nohgawa, Masaharu ^a   Kita, Kenkichi ^b   Iwasaki, Hiromichi ^c   Ueda, Takanori ^c   Takahashi, Atsushi ^a   Sasada, Masataka ^a  

^a KYOTO UNIVERSITY   (Japan)

^b MIE UNIVERSITY   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

Acute leukaemia; B7 2; Co stimulatory molecule; Prognosis; Tumour immunity

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL STIMULATION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; LEUKEMIA CELL; LYMPHOKINE ACTIVATED KILLER CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ACUTE DISEASE; ADULT; AGED; CHROMOSOME ABERRATIONS; DISEASE-FREE SURVIVAL; FEMALE; HLA-B7 ANTIGEN; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PROGNOSIS;

EID: 7344257238     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00901.x     Document Type: Article

References (28)

1. Archimbaud, E., Thomas, X., Campos, L., Fiere, D. & Dore, J.F. (1992) Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance. Leukemia Research, 16, 673-680.
2. Archimbaud, E., Thomas, X., Campos, L., Magaud, J.P., Fiere, D. & Dore, J.F. (1991) Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells. Leukemia, 5, 967-971.
3. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J.H., Lanier, L.L. & Somoza, C. (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature, 366, 76-79.
4. Chen, L., Ashe, S., Brady, W.A., Hellstrom, I., Hellstrom, K.E., Ledbetter, J.A., McGowan, P. & Linsley, P.S. (1992) Co-stimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71, 1093-1102.
5. Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellstrom, I. & Hellstrom, K.E. (1994) Tumor immunogenicity determines the effect of B 7 costimulation on T cell-mediated tumor immunity. Journal of Experimental Medicine, 179, 523-S32.
6. Dunussi Joannopoulos, K., Weinstein, H.J., Nickerson, P.W., Strom, T.B., Burakoff, S.J., Croop, J.M. & Arced, R.J. (1996) Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood, 87, 2938-2946.
7. Freedman, A.S., Freeman, G.J., Rhynhart, K. & Nadler, L.M. (1991) Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunology, 137, 429-437.
8. Freeman, G.J., Gribben, J.G., Boussiotis, V.A., Ng, J.W., Restivo, V.A., Jr, Lombard, L.A., Gray, G.S. & Nadler, L.M. (1993) Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science, 262, 909-911.
9. Gimmi, C.D., Freeman, G.J., Gribben, J.G., Sugita, K., Freedman, A.S., Morimoto, C. & Nadler, L.M. (1991) B-cell surface antigen B7 provides a co-stimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proceedings of the National Academy of Sciences of the United States of America, 88, 6575-6579.
10. Hoelzer, D., Ludwig, W-D., Thiel, E., Gaszmann, W. Loffler, H., Fonatsch, C., Rieder, U., Heil, G., Heinze, B., Arnold, R., Hossfeld, D., Buchner, T., Koch, P., Freund, M., Hiddemann, W., Maschmeyer, G., Heyll, A., Aul, C., Faak, T., Kuse, R., Ittel, T.H., Gramatzki, M., Diedrich, H., Kolbe, K., Furh, H-G., Fischer, K., Schadeck-Gressel, C., Weiss, A., Strohscheer, I., Metzner, B., Fabry, U., Gokbuget, N., Volkers, B., Messerer, D. & Uberla, K. (1996) Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood, 87, 495-508.
11. Jenkins, M.K., Taylor, P.S., Norton, S.D. & Urdahl, K.B. (1991) CD28 delivers a co-stimulatory signal involved in antigen-specific IL-2 production by human T cells. Journal of Immunology, 147, 2461-2466.
12. June, C.H., Ledbetter, J.A., Linsley, P.S. & Thompson, C.B. (1990) Role of the CD28 receptor in T-cell activation. Immunology Today, 11, 211-216.
13. Kakita, T., Sasada, M., Moriguchi, T., Nishimura, T., Yamamoto, K. & Uchino, H. (1989) Lysis of human leukemic cells by monocyte-derived macrophages activated with interferon-gamma and interleukin-2. Japanese Journal of Cancer Research, 80, 59-64.
14. Koyasu, S., Lawton, T., Novick, D., Recny, M.A., Siliciano, R.F., Wallner, B.P & Reinherz, E.L. (1990) Role of interaction of CD2 molecules with lymphocyte function-associated antigen 5 in T-cell recognition of nominal antigen. Proceedings of the National Academy of Sciences of the United States of America, 87, 2605-2607.
15. Krummel, M.F. & Allison J.P. (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. Journal of Experimental Medicine, 182, 459-465.
16. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N. & Glimcher, L.H. (1995) B7-1 and B7-2 co-stimulatory molecules activate differentially the Th1/ Th2 developmental pathways: application to autoimmune disease therapy. Cell, 80, 707-718.
17. Lauria, F., Raspadori, D., Rondelli, D., Ventura, M.A. & Foa, R. (1994) In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival. Leukemia, 8, 724-728.
18. Ledbetter, J.A., Imboden, J.B., Schieven, G.L., Grosmaire, L.S., Rabinovitch, P.S., Lindsten, T., Thompson, C.B. & June, C.H. (1990) CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood, 75, 1531-1539.
19. Linsley, P.S., Clark, E.A. & Ledbetter, J.A. (1990) T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proceedings of the National Academy of Sciences of the United States of America, 87, 5051-5055.
20. Matulonis, U., Dosiou, C., Freeman, G., Lament, C., Mauch, P., Nadler, L.M. & Griffin, J.D. (1996) B7-1 is superior to B7-2 co-stimulation in the induction and maintenance of T cell-mediated antileukemia immunity: further evidence that B7-1 and B7-2 are functionally distinct. Journal of Immunology, 156, 1126-1131.
21. Mosmann, T.R. & Coffman, R.L. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Animal Reviews of Immunology, 7, 145-175.
22. Nakabo, Y., Harakawa, N., Yamamoto, K., Okuma, M., Uno, K. & Sasada, M. (1993) Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor. Japanese Journal of Cancer Research, 84, 1174-1180.
23. Ohno, R., Kobayashi, T., Tanimoto, M., Hiraoka, A., Imai, K., Asou, N., Tomonaga, M. Tsubaki, K., Takahashi, I., Kodera, Y., Yoshida, M., Murukami, H., Naoe, T., Shimoyama, M., Tsukada, T., Takeo, T., Teshima, H., Onozawa, Y., Fujimoto, K., Kuriyama, K., Horiuchi, A., Kimura, I., Minami, S., Miura, Y., Kageyama, S., Tahara, T., Masaoka, T., Shirakawa, S. & Saito, H. (1993) Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia: AML87 study of the Japan Adult Leukemia Study Group. Cancer, 71, 3888-2895.
24. Powrie, F. & Coffman, R.L. (1993) Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunology Today, 14, 270-274.
25. Schwartz, R.H. (1992) Co-stimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell, 71, 1065-1068.
26. + T cells by B7-transfected melanoma cells. Science, 259, 368-370.
27. Van Seventer, G.A., Shimizu, Y., Morgan, K.J. & Shaw, S. (1990) The LFA-1 ligand [CAM-1 provides an important co-stimulatory signal for T cell receptor-mediated activation of resting T cells. Journal of Immunology, 144, 4579-4586.
28. Yokochi, T., Holly, R.O. & Clark, K.A. (1982) B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. Journal of Immunology, 128, 823-827.